Contemporary Treatment Approaches for Human Immunodeficiency Virus Infection: Association of Antiretrovirals with Weight Gain and Potential Solutions

被引：0
|
作者：
Shroba, Jenny [1 ]
Januszka, Jenna [1 ]
机构：
[1] Duke Univ Hosp, Dept Pharm, 40 Duke Med Circle, Durham, NC 27710 USA
来源：
NURSING CLINICS OF NORTH AMERICA | 2024年 / 59卷 / 02期
关键词：
Integrase inhibitors; Tenofovir alafenamide; Antiretrovirals; Weight gain; TENOFOVIR DISOPROXIL FUMARATE; HIV-INFECTION; BODY-COMPOSITION; DOUBLE-BLIND; ALAFENAMIDE; INHIBITORS; OBESITY; PEOPLE; EMTRICITABINE; DOLUTEGRAVIR;
D O I：
10.1016/j.cnur.2024.01.004
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
[No abstract available]
引用
收藏
页码：189 / 200
页数：12
相关论文
共 50 条
  • [31] Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis
    Turvey, Shannon L.
    Saxinger, Lynora
    Mason, Andrew L.
    VIRUSES-BASEL, 2022, 14 (03):
  • [32] Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection
    Tawakol, Ahmed
    Ishai, Amorina
    Li, Danny
    Takx, Richard A. P.
    Hur, Sophia
    Kaiser, Yannick
    Pampaloni, Miguel
    Rupert, Adam
    Hsu, Denise
    Sereti, Irini
    Fromentin, Remi
    Chomont, Nicolas
    Ganz, Peter
    Deeks, Steven G.
    Hsue, Priscilla Y.
    JAMA CARDIOLOGY, 2017, 2 (02) : 163 - 171
  • [33] Association between Schistosoma haematobium Exposure and Human Immunodeficiency Virus Infection among Females in Mozambique
    Brodish, Paul Henry
    Singh, Kavita
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 94 (05) : 1040 - 1044
  • [34] Meta-analytical Studies on the Epidemiology, Prevention, and Treatment of Human Immunodeficiency Virus Infection
    Vergidis, Paschalis I.
    Falagas, Matthew E.
    Hamer, Davidson H.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2009, 23 (02) : 295 - +
  • [35] 12-week Dolutegravir treatment marginally reduces energy expenditure but does not increase body weight or alter vascular function in a murine model of Human Immunodeficiency Virus infection
    Kress, Taylor C.
    Ajala, Priscilla
    Jordan, Coleton R.
    Mintz, James
    Macarthur, Rodger
    Kennard, Simone
    Antonova, Galina
    de Chantem, Eric J. Belin
    VASCULAR PHARMACOLOGY, 2024, 155
  • [36] Vertical human immunodeficiency virus-1 infection: Involvement of the central nervous system and treatment
    Exhenry, C
    Nadal, D
    EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (10) : 839 - 850
  • [37] Heart Failure in Patients With Human Immunodeficiency Virus Infection Epidemiology, Pathophysiology, Treatment, and Future Research
    Remick, Joshua
    Georgiopoulou, Vasiliki
    Marti, Catherine
    Ofotokun, Igho
    Kalogeropoulos, Andreas
    Lewis, William
    Butler, Javed
    CIRCULATION, 2014, 129 (17) : 1781 - 1789
  • [38] Epigenome-wide epidemiologic studies of human immunodeficiency virus infection, treatment, and disease progression
    Titanji, Boghuma K.
    Gwinn, Marta
    Marconi, Vincent C.
    Sun, Yan, V
    CLINICAL EPIGENETICS, 2022, 14 (01)
  • [39] Clinical management of acute and chronic human immunodeficiency virus infection before starting antiretroviral treatment
    Miro, Jose M.
    Manzardo, Christian
    Zamora, Laura
    Pumarola, Tomas
    Herreras, Zoe
    Gallart, Teresa
    Gatell, Jose M.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (10): : 759 - 772
  • [40] Impact of Delaying Antiretroviral Treatment During Primary Human Immunodeficiency Virus Infection on Telomere Length
    Raffenberg, Marieke
    Engel, Tanja
    Schoepf, Isabella C.
    Kootstra, Neeltje A.
    Reiss, Peter
    Braun, Dominique L.
    Thorball, Christian W.
    Fellay, Jacques
    Kouyos, Roger D.
    Ledergerber, Bruno
    Guenthard, Huldrych F.
    Tarr, Philip E.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (10) : 1775 - 1784
12345